The Relapse from MRD Negativity As Indication for Treatment (REMNANT) Study
Clinical trial NCT04513639 · RECRUITING
Trial details
- NCT number
- NCT04513639
- Sponsor
- Oslo University Hospital
- Status
- RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-08-27
- Primary completion
- 2031-06-01
- Enrollment
- 176
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.